Facile access to chiral <i>anti</i>-1,2-diol derivatives <i>via</i> Ir-catalyzed asymmetric hydrogenation of α-alkoxy-β-ketoesters

The iridium-catalyzed asymmetric hydrogenation of α-alkoxy-β-ketoesters <i>via</i> dynamic kinetic resolution has been achieved with high efficiency and enantioselectivity. This strategy allows for the synthesis of differentiated <i>anti</i>-1,2-diol derivatives in high yields, exhibiting excellent enantio- and diastereoselectivity (up to 99% yield, 99% ee, and 99 : 1 dr). Additionally, high turnover number (TON) experiments (up to 1000 TON) and gram-scale synthesis of a key fragment of the potential drug Tesaglitazar were successfully performed, highlighting the protocol's potential for broader applications.

Authors

Institutions

Publication Details

Journal
Chemical Communications
Published
2024-12-12
DOI
https://doi.org/10.1039/d4cc05644b
Citations
2
Primary Topic
Asymmetric Hydrogenation and Catalysis
Type
article
Field-Weighted Citation Impact
0.32

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Facile access to chiral anti-1,2-diol derivatives via Ir-catalyzed asymmetric hydrogenation of α-alkoxy-β-ketoesters

Gen‐Qiang Chen, Xumu Zhang, Bin Lü, Yuanzheng Wang
2 citations
Chemical Communications
Asymmetric Hydrogenation and Catalysis
0.32
article

Facile access to chiral anti-1,2-diol derivatives via Ir-catalyzed asymmetric hydrogenation of α-alkoxy-β-ketoesters

Gen‐Qiang Chen, Xumu Zhang, Bin Lü, Yuanzheng Wang
article en
2 citations

Abstract

The iridium-catalyzed asymmetric hydrogenation of α-alkoxy-β-ketoesters <i>via</i> dynamic kinetic resolution has been achieved with high efficiency and enantioselectivity. This strategy allows for the synthesis of differentiated <i>anti</i>-1,2-diol derivatives in high yields, exhibiting excellent enantio- and diastereoselectivity (up to 99% yield, 99% ee, and 99 : 1 dr). Additionally, high turnover number (TON) experiments (up to 1000 TON) and gram-scale synthesis of a key fragment of the potential drug Tesaglitazar were successfully performed, highlighting the protocol's potential for broader applications.

Chemical CommunicationsVol. 61(6)
Southern University of Science and Technology (CN), Ji Hua Laboratory (CN)
Natural Science Foundation of Shenzhen City, Science and Technology Foundation of Shenzhen City, National Natural Science Foundation of China, National Key Research and Development Program of China, Guangzhou Science and Technology Innovation Center, Basic and Applied Basic Research Foundation of Guangdong Province
Openalex Percentile: Top 47%
Asymmetric Hydrogenation and Catalysis
0.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.